Microcins mediate competition among Enterobacteriaceae in the inflamed gut
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The Enterobacteriaceae are a family of Gram-negative bacteria that include commensal organisms as well as primary and opportunistic pathogens that are among the leading causes of morbidity and mortality worldwide. Although Enterobacteriaceae often comprise less than 1% of a healthy intestine's microbiota, some of these organisms can bloom in the inflamed gut; expansion of enterobacteria is a hallmark of microbial imbalance known as dysbiosis. Microcins are small secreted proteins that possess antimicrobial activity in vitro, but whose role in vivo has been unclear. Here we demonstrate that microcins enable the probiotic bacterium Escherichia coli Nissle 1917 (EcN) to limit the expansion of competing Enterobacteriaceae (including pathogens and pathobionts) during intestinal inflammation. Microcin-producing EcN limits the growth of competitors in the inflamed intestine, including commensal E. coli, adherent-invasive E. coli and the related pathogen Salmonella enterica. Moreover, only therapeutic administration of the wild-type, microcin-producing EcN to mice previously infected with S. enterica substantially reduced intestinal colonization by the pathogen. Our work provides the first evidence that microcins mediate inter- and intraspecies competition among the Enterobacteriaceae in the inflamed gut. Moreover, we show that microcins can act as narrow-spectrum therapeutics to inhibit enteric pathogens and reduce enterobacterial blooms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, E. coli strain Nissle targets the uptake of siderophore‐bound iron by pathogenic Enterobacteriaceae – such as Salmonella – by secreting microcins, small anti‐bacterial molecules that bind bacteria via their catecholate siderophore receptors. 170”
From The battle for iron in enteric infections (2020) · cites this paper as [170]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Gut biogeography of the bacterial microbiota
Donaldson, G. P., Lee, S. M., & Mazmanian, S. K. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro3552 · Cited by 2,535
Control of pathogens and pathobionts by the gut microbiota
Kamada, N., Chen, G. Y., Inohara, N., & Núñez, G. (2013) · Nature Immunology · doi:10.1038/ni.2608 · Cited by 1,625
Microbiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens
Ng, K. M., Ferreyra, J. A., Higginbottom, S. K., Lynch, J. B., Kashyap, P. C., Gopinath, S., Naidu, N., Choudhury, B., Weimer, B. C., Monack, D. M., et al. (2013) · Nature · doi:10.1038/nature12503 · Cited by 1,035
Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut
Winter, S. E., Winter, M. G., Xavier, M. N., Thiennimitr, P., Poon, V., Keestra, A. M., Laughlin, R. C., Gomez, G., Wu, J., Lawhon, S. D., et al. (2013) · Science · doi:10.1126/science.1232467 · Cited by 1,019
Antibacterial activities of bacteriocins: application in foods and pharmaceuticals
Yang, S.-C., Lin, C.-H., Sung, C. T., & Fang, J.-Y. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00241 · Cited by 726
Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for Iron
Deriu, E., Liu, J. Z., Pezeshki, M., Edwards, R. A., Ochoa, R. J., Contreras, H., Libby, S. J., Fang, F. C., & Raffatellu, M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.06.007 · Cited by 550
Self-citationRaffatellu, M., George, M. D., Akiyama, Y., Hornsby, M. J., Nuccio, S.-P., Paixao, T. A., Butler, B. P., Chu, H., Santos, R. L., Berger, T., et al. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.03.011 · Cited by 525
Self-citation
Cited by
Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease
Pickard, J. M., Zeng, M. Y., Caruso, R., & Núñez, G. (2017) · Immunological Reviews · doi:10.1111/imr.12567 · Cited by 1,699
The One Health Concept: 10 Years Old and a Long Road Ahead
Destoumieux-Garzón, D., Mavingui, P., Boetsch, G., Boissier, J., Darriet, F., Duboz, P., Fritsch, C., Giraudoux, P., Le Roux, F., Morand, S., et al. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00014 · Cited by 992
“Similarly, antimicrobial peptides, effectors of innate immunity in metazoans, and competition in prokaryotes can also influence pathogen dynamics (51, 52), vector-borne transmission (53), and may allow alternative routes of transmission in the natural environment (54).”
BackgroundBacterial siderophores in community and host interactions
Kramer, J., Özkaya, Ö., & Kümmerli, R. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0284-4 · Cited by 998
Fassarella, M., Blaak, E. E., Penders, J., Nauta, A., Smidt, H., & Zoetendal, E. G. (2021) · Gut · doi:10.1136/gutjnl-2020-321747 · Cited by 772
Host–microbiota interactions in inflammatory bowel disease
Caruso, R., Lo, B. C., & Núñez, G. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-019-0268-7 · Cited by 780
Mechanisms and consequences of intestinal dysbiosis
Weiss, G. A., & Hennet, T. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2509-x · Cited by 775
The intestinal microbiota: Antibiotics, colonization resistance, and enteric pathogens
Kim, S., Covington, A., & Pamer, E. G. (2017) · Immunological Reviews · doi:10.1111/imr.12563 · Cited by 741
Pathogen elimination by probiotic Bacillus via signalling interference
Piewngam, P., Zheng, Y., Nguyen, T. H., Dickey, S. W., Joo, H.-S., Villaruz, A. E., Glose, K. A., Fisher, E. L., Hunt, R. L., Li, B., et al. (2018) · Nature · doi:10.1038/s41586-018-0616-y · Cited by 644
The Gut Microbiota in Inflammatory Bowel Disease
Qiu, P., Ishimoto, T., Fu, L., Zhang, J., Zhang, Z., & Liu, Y. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.733992 · Cited by 591
“coli Nissle 1917, and the combination of treatment and diet will achieve twofold results with half the effort (Sassone-Corsi et al., 2016).”
BackgroundGut Microbiota and Colonization Resistance against Bacterial Enteric Infection
Ducarmon, Q. R., Zwittink, R. D., Hornung, B. V. H., van Schaik, W., Young, V. B., & Kuijper, E. J. (2019) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00007-19 · Cited by 566
“inhibit Salmonella enterica serovar Typhimurium in vitro and in vivo (61).”
BackgroundBacteriocins as a new generation of antimicrobials: toxicity aspects and regulations
Soltani, S., Hammami, R., Cotter, P. D., Rebuffat, S., Said, L. B., Gaudreau, H., Bédard, F., Biron, E., Drider, D., & Fliss, I. (2021) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa039 · Cited by 544
Precision editing of the gut microbiota ameliorates colitis
Zhu, W., Winter, M. G., Byndloss, M. X., Spiga, L., Duerkop, B. A., Hughes, E. R., Büttner, L., de Lima Romão, E., Behrendt, C. L., Lopez, C. A., et al. (2018) · Nature · doi:10.1038/nature25172 · Cited by 548
A Gut Commensal-Produced Metabolite Mediates Colonization Resistance to Salmonella Infection
Jacobson, A., Lam, L., Rajendram, M., Tamburini, F., Honeycutt, J., Pham, T., Van Treuren, W., Pruss, K., Stabler, S. R., Lugo, K., et al. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.07.002 · Cited by 507
“Commensal bacteria mediate colonization resistance against pathogens through direct antibacterial mechanisms such as production of antagonistic molecules or direct niche competition (Maltby et al., 2013; Sassone-Corsi et al., 2016), as well as via indirect mechanisms such as enhancing host immunity (Abt et al.”
BackgroundThe Evolution and Ecology of Bacterial Warfare
Granato, E. T., Meiller-Legrand, T. A., & Foster, K. R. (2019) · Current Biology · doi:10.1016/j.cub.2019.04.024 · Cited by 531
“Further specificity may be achieved by identifying probiotic species that release toxins right next to a pathogen being targeted [51,206].”
Microbiota-mediated colonization resistance: mechanisms and regulation
Caballero-Flores, G., Pickard, J. M., & Núñez, G. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00833-7 · Cited by 474
Sorbara, M. T., & Pamer, E. G. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00667-9 · Cited by 468
Using probiotics to improve swine gut health and nutrient utilization
Liao, S. F., & Nyachoti, M. (2017) · Animal Nutrition · doi:10.1016/j.aninu.2017.06.007 · Cited by 443
“Microcin produced by probiotic E. coli can limit the growth of competitors in an inflamed intestine, including commensal E. coli, adherent-invasive E. coli, and the related pathogen Salmonella enterica (Setia et al., 2009; Bhandari et al., 2010; Krause et al., 2010; Sassone-Corsi et al., 2016).”
BackgroundLipocalin 2: an emerging player in iron homeostasis and inflammation
Xiao, X., Yeoh, B. S., & Vijay-Kumar, M. (2017) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071816-064559 · Cited by 426
The microbiome-shaping roles of bacteriocins
Heilbronner, S., Krismer, B., Brötz-Oesterhelt, H., & Peschel, A. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00569-w · Cited by 395
Thomas, S., Izard, J., Walsh, E., Batich, K., Chongsathidkiet, P., Clarke, G., Sela, D. A., Muller, A. J., Mullin, J. M., Albert, K., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2929 · Cited by 367
“A recent study demonstrated that microcins, the small proteins secreted by several favorable bacteria could limit the expansion of competing Enterobacteriaceae (299).”
BackgroundInfluentialBacterial antagonism in host-associated microbial communities
García-Bayona, L., & Comstock, L. E. (2018) · Science · doi:10.1126/science.aat2456 · Cited by 373
Cao, Z., Wang, X., Pang, Y., Cheng, S., & Liu, J. (2019) · Nature Communications · doi:10.1038/s41467-019-13727-9 · Cited by 337
Sorbara, M. T., & Pamer, E. G. (2019) · Mucosal Immunology · doi:10.1038/s41385-018-0053-0 · Cited by 320
Gut microbiota as a source of novel antimicrobials
Garcia-Gutierrez, E., Mayer, M. J., Cotter, P. D., & Narbad, A. (2019) · Gut Microbes · doi:10.1080/19490976.2018.1455790 · Cited by 292
“coli Nissle 1917, a probiotic originally isolated from the human gut, a competitive advantage.(145) This is the first evidence of the ecological role that microcins might play in the gut and opens a door to further therapeutical applications.”
BackgroundThe Commensal Microbiota and Viral Infection: A Comprehensive Review
Li, N., Ma, W.-T., Pang, M., Fan, Q.-L., & Hua, J.-L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01551 · Cited by 283
Bacteriocin-Producing Probiotic Lactic Acid Bacteria in Controlling Dysbiosis of the Gut Microbiota
Anjana, & Tiwari, S. K. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.851140 · Cited by 264
The microbiome in inflammatory bowel diseases: from pathogenesis to therapy
Liu, S., Zhao, W., Lan, P., & Mou, X. (2021) · Protein & Cell · doi:10.1007/s13238-020-00745-3 · Cited by 263
Commensal Enterobacteriaceae Protect against Salmonella Colonization through Oxygen Competition
Litvak, Y., Mon, K. K. Z., Nguyen, H., Chanthavixay, G., Liou, M., Velazquez, E. M., Kutter, L., Alcantara, M. A., Byndloss, M. X., Tiffany, C. R., et al. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2018.12.003 · Cited by 269
Microbiota Metabolites in Health and Disease
McCarville, J. L., Chen, G. Y., Cuevas, V. D., Troha, K., & Ayres, J. S. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-071219-125715 · Cited by 241
Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis
Fang, J., Wang, H., Zhou, Y., Zhang, H., Zhou, H., & Zhang, X. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00617-8 · Cited by 240
Fábrega, M.-J., Rodríguez-Nogales, A., Garrido-Mesa, J., Algieri, F., Badía, J., Giménez, R., Gálvez, J., & Baldomà, L. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01274 · Cited by 240
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
Lynch, J. P., Goers, L., & Lesser, C. F. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2022.02.002 · Cited by 230
A novel approach to Lactiplantibacillus plantarum: From probiotic properties to the omics insights
Echegaray, N., Yilmaz, B., Sharma, H., Kumar, M., Pateiro, M., Ozogul, F., & Lorenzo, J. M. (2023) · Microbiological Research · doi:10.1016/j.micres.2022.127289 · Cited by 209
Auffret, M. D., Dewhurst, R. J., Duthie, C.-A., Rooke, J. A., John Wallace, R., Freeman, T. C., Stewart, R., Watson, M., & Roehe, R. (2017) · Microbiome · doi:10.1186/s40168-017-0378-z · Cited by 214
“[58] and also carrying microcin synthesis genes providing a competitive advantage against enteric pathogens [57] when feeding a high-forage diet, which is known to promote”
BackgroundSalmonella versus the Microbiome
Rogers, A. W. L., Tsolis, R. M., & Bäumler, A. J. (2021) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00027-19 · Cited by 205
“However, the T6SS is only induced when inflammation increases the concentration of bile acids (201), and neither microcins nor colicins provide a competitive advantage in the absence of intestinal inflammation because iron limitation generated by this host response induces expression of receptors for microcins and col…”
BackgroundMolecular mechanisms of probiotic prevention of antibiotic-associated diarrhea
Mekonnen, S. A., Merenstein, D., Fraser, C. M., & Marco, M. L. (2020) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2020.01.005 · Cited by 191
“coli Nissle 1917 was found to produce a class of bacteriocins that limit the expansion of competing Enterobacteriaceae during intestinal inflammation [27].”
BackgroundYang, X., Yang, J., Ye, Z., Zhang, G., Nie, W., Cheng, H., Peng, M., Zhang, K., Liu, J., Zhang, Z., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c09681 · Cited by 194
Escherichia coli Residency in the Gut of Healthy Human Adults
Martinson, J. N. V., & Walk, S. T. (2020) · EcoSal Plus · doi:10.1128/ecosalplus.esp-0003-2020 · Cited by 197
“coli Nissle 1917 and competition in an inflamed gut environment (92,117).”
BackgroundProtective Microbiota: From Localized to Long-Reaching Co-Immunity
Chiu, L., Bazin, T., Truchetet, M.-E., Schaeverbeke, T., Delhaes, L., & Pradeu, T. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01678 · Cited by 190
Zhang, Y., Tan, P., Zhao, Y., & Ma, X. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2055943 · Cited by 180
“coli in infected mice.(148) GUT MICROBES e2055943-9”
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
Huang, I.-S., & Zimba, P. V. (2019) · Harmful Algae · doi:10.1016/j.hal.2018.11.008 · Cited by 181
Roles of the intestinal microbiota in pathogen protection
Ubeda, C., Djukovic, A., & Isaac, S. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2017.2 · Cited by 181
Interplay between gut microbiota and antimicrobial peptides
Zong, X., Fu, J., Xu, B., Wang, Y., & Jin, M. (2020) · Animal Nutrition · doi:10.1016/j.aninu.2020.09.002 · Cited by 176
Pathogens, microbiome and the host: emergence of the ecological Koch's postulates
Vonaesch, P., Anderson, M., & Sansonetti, P. J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy003 · Cited by 170
“Some of the bacteriocins and microcins have been shown to act against 352 pathogenic strains (Kommineni et al. 2015; Sassone-Corsi et al. 2016b), thereby augmenting colonization 353 resistance and mediating resistance to invading pathogens.”
BackgroundMicrocins in Enterobacteriaceae: Peptide Antimicrobials in the Eco-Active Intestinal Chemosphere
Baquero, F., Lanza, V. F., Baquero, M.-R., del Campo, R., & Bravo-Vázquez, D. A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02261 · Cited by 171
“High cell density or local inflammation also increases competition for critical nutrients, such as iron, in such a way that favors the uptake of siderophoremicrocins (Sassone-Corsi et al., 2016).”
BackgroundEberl, C., Weiss, A. S., Jochum, L. M., Durai Raj, A. C., Ring, D., Hussain, S., Herp, S., Meng, C., Kleigrewe, K., Gigl, M., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.09.004 · Cited by 170
Gut Microbiota, Endocrine-Disrupting Chemicals, and the Diabetes Epidemic
Velmurugan, G., Ramprasath, T., Mithieux, G., Swaminathan, K., & Ramasamy, S. (2017) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2017.05.001 · Cited by 174
“Microcins, small peptide narrow-spectrum antibiotics that are effective against specific groups of bacteria, could conceivably be used as a targeted strategy to restore a healthy microbiota [69].”
BackgroundMicrobiome therapeutics: exploring the present scenario and challenges
Yadav, M., & Chauhan, N. S. (2021) · Gastroenterology report · doi:10.1093/gastro/goab046 · Cited by 179
“Antibiotic microcin H47 Pathogen-growth inhibition Displaced Salmonella enterica from gut [92]”
Dietary l-serine confers a competitive fitness advantage to Enterobacteriaceae in the inflamed gut
Kitamoto, S., Alteri, C. J., Rodrigues, M., Nagao-Kitamoto, H., Sugihara, K., Himpsl, S. D., Bazzi, M., Miyoshi, M., Nishioka, T., Hayashi, A., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-019-0591-6 · Cited by 158
The Central Role of Interbacterial Antagonism in Bacterial Life
Peterson, S. B., Bertolli, S. K., & Mougous, J. D. (2020) · Current Biology · doi:10.1016/j.cub.2020.06.103 · Cited by 162
“coli Nissle suppresses the growth of invading Salmonella through the production of antimicrobial peptides called microcins, which are induced in response to low iron, a hallmark of the inflamed gut [95].”
Antibacterial Weapons: Targeted Destruction in the Microbiota
Chassaing, B., & Cascales, E. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.01.006 · Cited by 160
Fischer, A. J., Song, Y., He, Z., Haines, D. M., Guan, L. L., & Steele, M. A. (2018) · Journal of Dairy Science · doi:10.3168/jds.2017-13397 · Cited by 200
“On the other hand, in mammals, generic E. coli can also benefit the host by preventing the colonization of pathogenic bacteria (Reid et al., 2001), producing vitamin K 2 (Sharma et al., 1992), and limiting the growth of competitive bacteria in the inflamed intestine (Sassone-Corsi et al., 2016).”
BackgroundThe expanding structural variety among bacteriocins from Gram-positive bacteria
Acedo, J. Z., Chiorean, S., Vederas, J. C., & van Belkum, M. J. (2018) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuy033 · Cited by 170
Yan, X., Liu, X.-Y., Zhang, D., Zhang, Y., Li, Z., Liu, X., Wu, F., & Chen, G. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00760-2 · Cited by 161
Secher, T., Kassem, S., Benamar, M., Bernard, I., Boury, M., Barreau, F., Oswald, E., & Saoudi, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01096 · Cited by 148
“It is also possible that ECN may reduce microbial imbalance in the EAE gut through inter or intraspecies competition, for which ECN genome encodes specialized molecules (60).”
BackgroundEngineering probiotics as living diagnostics and therapeutics for improving human health
Zhou, Z., Chen, X., Sheng, H., Shen, X., Sun, X., Yan, Y., Wang, J., & Yuan, Q. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01318-z · Cited by 145
Liu, Q., Liu, Q., Meng, H., Lv, H., Liu, Y., Liu, J., Wang, H., He, L., Qin, J., Wang, Y., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2019.11.003 · Cited by 148
Antibiotic-induced collateral damage to the microbiota and associated infections
de Nies, L., Kobras, C. M., & Stracy, M. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00936-9 · Cited by 169
“These can be direct, through interbacterial interactions such as nutrient competition 71,72 or secretion of bacte-riocins and other antimicrobials 73 .”
BackgroundIntestinal colonization resistance in the context of environmental, host, and microbial determinants
Woelfel, S., Silva, M. S., & Stecher, B. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.05.002 · Cited by 164
The manifold roles of microbial ribosomal peptide–based natural products in physiology and ecology
Li, Y., & Rebuffat, S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.006545 · Cited by 155
“However, microcins M and H47 were recently demonstrated for the first time to mediate competition among Enterobacteriaceae exclusively in the inflamed gut, which represents highly competitive conditions for resources, and particularly for iron (110).”
BackgroundWotzka, S. Y., Nguyen, B. D., & Hardt, W. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.03.009 · Cited by 151
Bacteriocins: Potential for Human Health
Huang, F., Teng, K., Liu, Y., Cao, Y., Wang, T., Ma, C., Zhang, J., & Zhong, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/5518825 · Cited by 146
“coli MC4100 Inhibiting intestinal pathogenic bacteria and reducing intestinal inflammation [77]”
BackgroundPalmer, J. D., Piattelli, E., McCormick, B. A., Silby, M. W., Brigham, C. J., & Bucci, V. (2018) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.7b00114 · Cited by 133
Next generation probiotics: Engineering live biotherapeutics
Murali, S. K., & Mansell, T. J. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108336 · Cited by 153
Bioengineered Escherichia coli Nissle 1917 for tumour‐targeting therapy
Yu, X., Lin, C., Yu, J., Qi, Q., & Wang, Q. (2019) · Microbial Biotechnology · doi:10.1111/1751-7915.13523 · Cited by 158
“, 2005), (ii) antimicrobial activity through secretion of microcins and bacteriocins (Sassone-Corsi et al., 2016), and (iii) formation of biofilms resulting in the production of defensins (Lasaro et al.”
BackgroundThe role of gut microbiota in intestinal disease: from an oxidative stress perspective
Sun, Y., Wang, X., Li, L., Zhong, C., Zhang, Y., Yang, X., Li, M., & Yang, C. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1328324 · Cited by 178
“This reduction may result in a decline in beneficial bacteria associated with human health, such as commensal E. coli (Sassone-Corsi et al., 2016), while simultaneously promoting the growth of harmful microorganisms, including Salmonella enterica serovar Typhimurium and Proteobacteria…”
BackgroundHypoxia induces senescence of bone marrow mesenchymal stem cells via altered gut microbiota
Xing, J., Ying, Y., Mao, C., Liu, Y., Wang, T., Zhao, Q., Zhang, X., Yan, F., & Zhang, H. (2018) · Nature Communications · doi:10.1038/s41467-018-04453-9 · Cited by 130
Role of antimicrobial peptides in controlling symbiotic bacterial populations
Mergaert, P. (2018) · Natural Product Reports · doi:10.1039/c7np00056a · Cited by 147
Structural mechanism of transcription inhibition by lasso peptides microcin J25 and capistruin
Braffman, N. R., Piscotta, F. J., Hauver, J., Campbell, E. A., Link, A. J., & Darst, S. A. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1817352116 · Cited by 122
“Many RiPPs display potent antimicrobial activity and hold promise for therapeutic agents (43).”
BackgroundOliveira, R. A., Ng, K. M., Correia, M. B., Cabral, V., Shi, H., Sonnenburg, J. L., Huang, K. C., & Xavier, K. B. (2020) · Nature Microbiology · doi:10.1038/s41564-019-0658-4 · Cited by 137
Zhu, W., Miyata, N., Winter, M. G., Arenales, A., Hughes, E. R., Spiga, L., Kim, J., Sifuentes-Dominguez, L., Starokadomskyy, P., Gopal, P., et al. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181939 · Cited by 124
Ruminal acidosis, bacterial changes, and lipopolysaccharides
Monteiro, H. F., & Faciola, A. P. (2020) · Journal of Animal Science · doi:10.1093/jas/skaa248 · Cited by 152
The therapeutic potential of bacteriocins as protein antibiotics
Behrens, H. M., Six, A., Walker, D., & Kleanthous, C. (2017) · Emerging Topics in Life Sciences · doi:10.1042/etls20160016 · Cited by 124
The Intestinal Microbiota: Impacts of Antibiotics Therapy, Colonization Resistance, and Diseases
Shah, T., Baloch, Z., Shah, Z., Cui, X., & Xia, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126597 · Cited by 106
Ultrahigh-throughput functional profiling of microbiota communities
Terekhov, S. S., Smirnov, I. V., Malakhova, M. V., Samoilov, A. E., Manolov, A. I., Nazarov, A. S., Danilov, D. V., Dubiley, S. A., Osterman, I. А., Rubtsova, M. P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811250115 · Cited by 127
“The bactericide properties of microbiome spectra and bacterial coexistence are becoming a hallmark of present-day biomedical investigations in humans (5, 6).”
BackgroundBacteriocins and bacteriophage; a narrow-minded approach to food and gut microbiology
Mills, S., Ross, R. P., & Hill, C. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux022 · Cited by 127
Immune-Microbiota Interplay and Colonization Resistance in Infection
Leshem, A., Liwinski, T., & Elinav, E. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.03.001 · Cited by 128
Pediocin-like bacteriocins: new perspectives on mechanism of action and immunity
Colombo, N. S. R., Chalón, M. C., Navarro, S. A., & Bellomio, A. (2017) · Current Genetics · doi:10.1007/s00294-017-0757-9 · Cited by 120
Learning from bacterial competition in the host to develop antimicrobials
Raffatellu, M. (2018) · Nature Medicine · doi:10.1038/s41591-018-0145-0 · Cited by 118
Self-citationAntimicrobial Peptides and Copper(II) Ions: Novel Therapeutic Opportunities
Portelinha, J., Duay, S. S., Yu, S. I., Heilemann, K., Libardo, M. D. J., Juliano, S. A., Klassen, J. L., & Angeles-Boza, A. M. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00921 · Cited by 113
Probiotic Escherichia coli NISSLE 1917 for inflammatory bowel disease applications
Zhao, Z., Xu, S., Zhang, W., Wu, D., & Yang, G. (2022) · Food & Function · doi:10.1039/d2fo00226d · Cited by 112
Constante, M., Fragoso, G., Lupien-Meilleur, J., Calvé, A., & Santos, M. M. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000001089 · Cited by 106
Iyer, S. S., Gensollen, T., Gandhi, A., Oh, S. F., Neves, J. F., Collin, F., Lavin, R., Serra, C., Glickman, J., de Silva, P. S. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.04.037 · Cited by 107
“Within the commensal populations, these BGC-encoded small-molecule bacterial signaling factors collectively have an enormous potential to mediate microbemicrobe interactions (Lee et al., 2008; Mazmanian et al., 2008; Sassone-Corsi et al., 2016).”
Massip, C., Branchu, P., Bossuet-Greif, N., Chagneau, C. V., Gaillard, D., Martin, P., Boury, M., Sécher, T., Dubois, D., Nougayrède, J.-P., et al. (2019) · PLOS Pathogens · doi:10.1371/journal.ppat.1008029 · Cited by 107
“Genes involved in MccH47 and MccM synthesis were searched using BLASTn and the CA58 Mcc gene cluster as a reference: mchB and mcmA which encode precursor proteins, the immunity genes mchI and mcmI, genes mchE and mchF which encode a specific efflux pump, and genes mcmK and mcmL (and their respective homologs in the E.…”
BackgroundInfluentialSalmonella enterica Serovar Typhimurium Strategies for Host Adaptation
Anderson, C. J., & Kendall, M. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01983 · Cited by 119
“E. coli siderophores can be conjugated to microcins, small antibacterial peptides that kill bacterial cells through an unknown mechanism (Rebuffat, 2012; Sassone-Corsi et al., 2016).”
BackgroundFang, K., Jin, X., & Hong, S. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-23180-1 · Cited by 104
Luo, H., Wu, F. Q., Wang, X., Lin, S., Zhang, M., Cao, Z., & Liu, J. (2023) · Materials Today · doi:10.1016/j.mattod.2023.01.001 · Cited by 105
Siderophore-mediated zinc acquisition enhances enterobacterial colonization of the inflamed gut
Behnsen, J., Zhi, H., Aron, A. T., Subramanian, V., Santus, W., Lee, M. H., Gerner, R. R., Petras, D., Liu, J. Z., Green, K. D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27297-2 · Cited by 101
“Briefly, each of four histological criteria (mononuclear infiltration, edema, epithelial injury, and neutrophilic inflammation/crypt abscesses) was determined as absent (0), mild (1), moderate (2), or severe (3).”
BackgroundSelf-citationYu, H., Ding, X., Li, N., Zhang, X., Zeng, X., Wang, S., Liu, H., Wang, Y. M., Jia, H. M., & Qiao, S. (2017) · Journal of Animal Science · doi:10.2527/jas2017.1494 · Cited by 104
“Recently, a study reported that microcin-producing E. coli Nissle 1917 limited growth of competitors in an inflamed intestine, including commensal E. coli, adherentinvasive E. coli, and Salmonella enterica (Sassone-Corsi et al., 2016).”
BackgroundSelf-citationYu, H., Ding, X., Shang, L., Zeng, X., Liu, H., Li, N., Huang, S., Wang, Y., Wang, G., Cai, S., et al. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00242 · Cited by 100
“A previous study has also been indicated that microcins can conceivably be utilized as a targeted strategy to treat infection disease and enterobacterial colitis during administration to pathogen-infected and inflamed animals (Sassone-Corsi et al., 2016).”
BackgroundSelf-citationType VI Secretion Systems and the Gut Microbiota
Coyne, M. J., & Comstock, L. E. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.psib-0009-2018 · Cited by 117
Zhong, Y., Wang, T., Luo, R., Liu, J., Jin, R., & Peng, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2158174 · Cited by 107
“…, such as commensal E. coli , adherent invasive E. coli during the intestinal inflammatory response, which suggested that microcin M can act as narrow-spectrum therapeutics to limit the expansion of enteric pathogens and ameliorate enterobacterial blooms (Sassone-Corsi et al. 2016).”
BackgroundBacteriocins to Thwart Bacterial Resistance in Gram Negative Bacteria
Telhig, S., Said, L. B., Zirah, S., Fliss, I., & Rebuffat, S. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.586433 · Cited by 105
“…system (MccV, MccL) (Chehade and Braun, 1988; Morin et al., 2011), or the porin OmpF which screens incoming products in a non-specific manner (Sato et al., 2000; Kaeriyama et al., 2006) (MccPDI) (Zhao et al., 2015), while class I microcins either use FhuA (MccJ25) (Pugsley et al., 1986;…”
Fungi as Part of the Microbiota and Interactions with Intestinal Bacteria
Kapitan, M., Niemiec, M. J., Steimle, A., Frick, J.-S., & Jacobsen, I. D. (2018) · Current topics in microbiology and immunology · doi:10.1007/82_2018_117 · Cited by 116
Cyanobacterial bioactive metabolites—A review of their chemistry and biology
Huang, I., & Zimba, P. V. (2019) · Harmful Algae · doi:10.1016/j.hal.2019.05.001 · Cited by 106
Ishizaka, A., Koga, M., Mizutani, T., Parbie, P. K., Prawisuda, D., Yusa, N., Sedohara, A., Kikuchi, T., Ikeuchi, K., Adachi, E., et al. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00708-21 · Cited by 102
Weiß, A. S., Niedermeier, L., von Strempel, A., Burrichter, A. G., Ring, D., Meng, C., Kleigrewe, K., Lincetto, C., Hübner, J., & Stecher, B. (2023) · Nature Communications · doi:10.1038/s41467-023-40372-0 · Cited by 116
Metabolic ecology of microbiomes: Nutrient competition, host benefits, and community engineering
Bakkeren, E., Piskovsky, V., & Foster, K. R. (2025) · Cell Host & Microbe · doi:10.1016/j.chom.2025.05.013 · Cited by 104
“191 Another promising approach is to combine the power of nutrient competition with other mechanisms that suppress pathogens, including phage predation, 192 antimicrobial toxin-producing bacteria, 123 and vaccination that raises IgA antibodies specific to the surface glycans of target bacteria.”
Antimicrobial Characteristics of Lactic Acid Bacteria Isolated from Homemade Fermented Foods
Ren, D., Zhu, J., Gong, S., Liu, H., & Yu, H. (2018) · BioMed Research International · doi:10.1155/2018/5416725 · Cited by 90
“antimicrobial peptides and acids that are good biopreservatives for pickled products [8].”
BackgroundSelf-citationBacteriocins: potentials and prospects in health and agrifood systems
Reuben, R. C., & Torres, C. (2024) · Archives of Microbiology · doi:10.1007/s00203-024-03948-y · Cited by 99
Metadata
- Authors
- Sassone-Corsi, M., Nuccio, S.-P., Liu, H., Hernandez, D., Vu, C. T., Takahashi, A. A., Edwards, R. A., & Raffatellu, M.
- Affiliations
- University of California, Irvine (US)
- Corresponding author
- Raffatellu, Manuela
- Venue
- Nature
- Published
- 2016-10-31
- Volume
- 540
- Issue
- 7632
- Pages
- 280-283
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC5145735
- OpenAlex
- W2545187638
- Cited by
- 549
- References
- 29
- Citations by year
- 2026: 40 · 2025: 64 · 2024: 63 · 2023: 56 · 2022: 75 · 2021: 61 · 2020: 60 · 2019: 54 · 2018: 38 · 2017: 36 · 2016: 1
- FWCI
- 54.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI114625, R01AI083663, R56AI114625, R01AI126277, R21AI105374, R21AI101784, R37AI126277)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058057)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Microbiology › Escherichia coli research studies
- Keywords
- microcin, Enterobacteriaceae, intestinal inflammation, interspecific competition, intraspecific competition, Escherichia coli Nissle 1917, probiotics, dysbiosis, Salmonella enterica, adherent-invasive Escherichia coli, antimicrobial peptides, intestinal colonization, gut microbiota
- MeSH terms
- Animals, Bacteriocins, Enterobacteriaceae, Escherichia coli, Female, Inflammation, Intestinal Mucosa, Intestines, Male, Mice, Inbred C57BL, Symbiosis, Salmonella enterica, Probiotics, Mice, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.